8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

2,279

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Hypertension

Interventions

DRUG

Valsartan + amlodipine

DRUG

Valsartan + HCTZ

DRUG

Amlodipine + HCTZ

DRUG

Valsartan + amlodipine + HCTZ

Trial Locations (1)

Novartis Pharmaceuticals Corporation, East Hanover